NRX Pharmaceuticals, Inc.
Ticker: 1719406
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 |
|---|---|---|
| INCOME | ||
| Revenue | 1.07+345.8% | 0.24 |
| Total Income | 1.07+345.8% | 0.24 |
| EXPENSES | ||
| Expenditure | 5.81+36.1% | 4.27 |
| Tax | 0.00 | — |
| PROFIT | ||
| Net Profit | -1.43+75.7% | -5.89 |
| KEY METRICS | ||
| OPM % | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% |
| EPS | -0.04+85.2% | -0.27 |
Corporate Events
No corporate events found.